Cornercap Investment Counsel Inc Royalty Pharma PLC Transaction History

Cornercap Investment Counsel Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$27.46 - $31.33 $10,489 - $11,968	382 Added 0.57%	67,314 $2.04 Million
Q4 2023 Jan 30, 2024	BUY	$26.21 - $29.22 $903,799 - $1.01 Million	34,483 Added 106.27%	66,932 $1.88 Million
Q3 2023 Nov 13, 2023	BUY	$26.26 - $31.38 $162,155 - $193,771	6,175 Added 23.5%	32,449 $880,000
Q2 2023 Aug 11, 2023	BUY	$29.6 - $36.56 $62,012 - $76,593	2,095 Added 8.66%	26,274 $807,000
Q1 2023 May 11, 2023	BUY	$32.77 - $39.4 $792,345 - $952,652	24,179 New	24,179 $871,000

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.